Totient Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 18

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $100M

Totient General Information

Description

Developer of antibodies intended for applications in cell therapies, antibody-drug conjugates, and bispecifics. The company uses machine learning, advanced immunoinformatics, and knowledge of recent research to reconstruct antibodies from tissues affected by autoimmunity, infections, and cancer, collected from patients experiencing exceptional immune responses, enabling clinicians to avail antibody therapeutics to treat cancer and other autoimmune diseases.

Contact Information

Website
www.totient.bio
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1 Alewife Center
  • Suite 120
  • Cambridge, MA 02140
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Absci
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1 Alewife Center
  • Suite 120
  • Cambridge, MA 02140
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Totient Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 04-Jun-2021 $100M Completed Generating Revenue
5. Early Stage VC 05-Jan-2021 Completed Product Development
4. Early Stage VC 03-Oct-2020 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. Early Stage VC Completed Startup
To view Totient’s complete valuation and funding history, request access »

Totient Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibodies intended for applications in cell therapies, antibody-drug conjugates, and bispecifics. The comp
Drug Discovery
Cambridge, MA
18 As of 2021

Emeryville, CA
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Totient Competitors (45)

One of Totient’s 45 competitors is Fauna Bio, a Venture Capital-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fauna Bio Venture Capital-Backed Emeryville, CA
T3D Therapeutics Venture Capital-Backed Durham, NC
Alzheon Venture Capital-Backed Framingham, MA
Arvinas Formerly VC-backed New Haven, CT
IRulya Therapeutics Formerly VC-backed New Haven, CT
You’re viewing 5 of 45 competitors. Get the full list »

Totient Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Totient Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022125448-A1 Systems and methods for producing disease-associated protein compositions Inactive 07-Dec-2020
WO-2020223392-A2 Cancer associated antibody compositions and methods of use Inactive 30-Apr-2019
WO-2020223392-A3 Cancer associated antibody compositions and methods of use Inactive 30-Apr-2019
AU-2019342131-A1 Cancer associated antibody compositions and methods of use Inactive 19-Sep-2018
WO-2020061337-A1 Cancer associated antibody compositions and methods of use Inactive 19-Sep-2018 C07K16/3053
To view Totient’s complete patent history, request access »

Totient Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Totient Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brooks Hill Partners Venture Capital Minority
CerraCap Venture Capital Minority
Convergent Ventures (San Francisco) Venture Capital Minority
Das & Co. Family Office Minority
Helicase Venture Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Totient FAQs

  • When was Totient founded?

    Totient was founded in 2017.

  • Where is Totient headquartered?

    Totient is headquartered in Cambridge, MA.

  • What is the size of Totient?

    Totient has 18 total employees.

  • What industry is Totient in?

    Totient’s primary industry is Drug Discovery.

  • Is Totient a private or public company?

    Totient is a Private company.

  • What is the current valuation of Totient?

    The current valuation of Totient is .

  • What is Totient’s current revenue?

    The current revenue for Totient is .

  • How much funding has Totient raised over time?

    Totient has raised $10M.

  • Who are Totient’s investors?

    Brooks Hill Partners, CerraCap, Convergent Ventures (San Francisco), Das & Co., and Helicase Venture are 5 of 18 investors who have invested in Totient.

  • Who are Totient’s competitors?

    Fauna Bio, T3D Therapeutics, Alzheon, Arvinas, and IRulya Therapeutics are some of the 45 competitors of Totient.

  • When was Totient acquired?

    Totient was acquired on 04-Jun-2021.

  • Who acquired Totient?

    Totient was acquired by Absci.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process